Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons S.Y. (Sanne) Smith-Apeldoorn

Publicaties

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension

Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study

Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series

The antidepressant effect and safety of non-intranasal esketamine: A systematic review

Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review: A systematic review

Ketamine Treatment for Depression in Patients With a History of Psychosis or Current Psychotic Symptoms: A Systematic Review

Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review

Lees meer

Pers/media

‘Geef selecte groep depressiepatiënten langdurig ketamine’

‘Geef selecte groep depressiepatiënten langdurig ketamine’